Loading clinical trials...

Prevention of Diabetes After Transplantation by Vildagliptin in the Early Post-transplant Period | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNPhase 3NCT02849899

Prevention of Diabetes After Transplantation by Vildagliptin in the Early Post-transplant Period

Post-transplant diabetes affects 15 to 20% of renal transplant patients and contributes to increased morbidity and reduced survival of transplants and patients. Corticosteroids, anti-calcineurin and m...

Lead sponsor: Centre Hospitalier Universitaire de Besancon•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

Emilie Gaiffe, Dr.

CONTACT

0381218824 egaiffe@chu-besancon.fr

Ingrid Tissot

CONTACT

0381218427 itissot@chu-besancon.fr

Related studies

RECRUITING

A Natural History Study of Metabolic Sizing in Health and Disease

NCT05398783 · Metabolic Disorders, Cancer, and more

RECRUITINGPhase 2

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

NCT07224321 · Type 1 Diabetes Mellitus

RECRUITINGEARLY Phase 1

Autologous CD6-CAR Treg Cells for Patients With Stage 3 Type 1 Diabetes

NCT07395050 · Stage 3 Type 1 Diabetes

RECRUITINGNA

New Heart Imaging Techniques to Evaluate Possible Heart Disease

NCT01399385 · Healthy, Obesity, and more

RECRUITING

Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)

NCT07457580 · Type 1 Diabetes

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 2, 2022Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE3

Enrollment186

Start dateOct 2018

Last updatedAug 2, 2022

Condition

Locations shown

CHU de Besançon

Besançon

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 2, 2022Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions